Collectively, the results indicated that the levels of the three TME signature genes (CXCL10, IDO1, and MAB21L2) were all increased in CRC tissues when compared with the control tissues, but the expression of LZTS2 in CRC tissues remained need to further validate. The gene discussed is IDO1; the disease is colorectal carcinoma.